Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pericyte | 5 studies | 20% ± 4% | |
| retinal cone cell | 4 studies | 37% ± 11% | |
| adipocyte | 3 studies | 32% ± 2% | |
| type II pneumocyte | 3 studies | 23% ± 4% | |
| fibroblast | 3 studies | 20% ± 2% | |
| endothelial cell | 3 studies | 19% ± 2% | |
| microglial cell | 3 studies | 22% ± 4% |
Insufficient scRNA-seq data for expression of DIAPH2-AS1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 92% | 15.13 | 1328 / 1445 | 38% | 0.76 | 70 / 183 |
| lung | 96% | 9.20 | 554 / 578 | 10% | 0.31 | 118 / 1155 |
| bladder | 95% | 14.81 | 20 / 21 | 10% | 0.48 | 48 / 504 |
| prostate | 93% | 7.82 | 227 / 245 | 1% | 0.05 | 4 / 502 |
| ovary | 90% | 6.96 | 162 / 180 | 0% | 0 | 0 / 430 |
| uterus | 83% | 6.26 | 141 / 170 | 5% | 0.20 | 23 / 459 |
| intestine | 79% | 4.94 | 761 / 966 | 8% | 0.23 | 44 / 527 |
| adipose | 86% | 6.20 | 1036 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 84% | 6.26 | 1128 / 1335 | 0% | 0 | 0 / 0 |
| breast | 82% | 5.03 | 376 / 459 | 1% | 0.08 | 15 / 1118 |
| stomach | 71% | 3.77 | 256 / 359 | 12% | 0.46 | 33 / 286 |
| skin | 80% | 5.20 | 1440 / 1809 | 1% | 0.02 | 6 / 472 |
| spleen | 77% | 3.83 | 186 / 241 | 0% | 0 | 0 / 0 |
| thymus | 73% | 3.76 | 477 / 653 | 2% | 0.04 | 12 / 605 |
| liver | 65% | 2.67 | 146 / 226 | 1% | 0.01 | 3 / 406 |
| pancreas | 48% | 1.88 | 157 / 328 | 15% | 0.36 | 26 / 178 |
| heart | 59% | 2.73 | 506 / 861 | 0% | 0 | 0 / 0 |
| muscle | 55% | 2.19 | 439 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 49% | 1.73 | 126 / 258 | 3% | 0.05 | 6 / 230 |
| peripheral blood | 49% | 2.49 | 455 / 929 | 0% | 0 | 0 / 0 |
| kidney | 46% | 2.04 | 41 / 89 | 1% | 0.10 | 6 / 901 |
| brain | 40% | 1.44 | 1054 / 2642 | 0% | 0.01 | 2 / 705 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0005575 | Cellular component | cellular_component |
| Gene name | DIAPH2-AS1 |
| Protein name | Early lymphoid activation gene protein (DIAPH2 antisense RNA 1) (DIAPH2 antisense gene protein 1) |
| Synonyms | EPAG |
| Description | FUNCTION: May function as an early signal that helps mediate the activation of T-cells. . |
| Accessions | Q14236 |